Inventor · disambiguated record
Matthew I. Gross
Also filed as: GROSS MATTHEW · GROSS MATTHEW I
10 granted patents·10 pending applications·18 citations·filing 2007–2021
83Inventor score
Files withCALITHERA BIOSCIENCES INC12AVIGEN INC4GAETA FEDERICO C A2JOHNSON KIRK W1PARLATI FRANCESCO1
Top patents by PatentIndex Score
20 records- 0187US7585875B2Substituted pyrazolo[1,5-a]pyridine compounds and their methods of useAVIGEN INC·Filed 2007·Granted Sep 8, 2009·8 cites·9 claims
- 0283US10258619B2Combination therapy with glutaminase inhibitors and immuno-oncology agentsCALITHERA BIOSCIENCES INC·Filed 2016·Granted Apr 16, 2019·4 cites·20 claims
- 0380US10398714B2Compositions and methods for inhibiting arginase activityCALITHERA BIOSCIENCES INC·Filed 2018·Granted Sep 3, 2019·3 cites·48 claims
- 0480US10143699B2Compositions and methods for inhibiting arginase activityCALITHERA BIOSCIENCES INC·Filed 2016·Granted Dec 4, 2018·3 cites·16 claims
- 0569US10905701B2Compositions and methods for inhibiting arginase activityCALITHERA BIOSCIENCES INC·Filed 2019·Granted Feb 2, 2021·0 cites·30 claims
- 0668US2021077510A1Compositions and methods for inhibiting arginase activityCALITHERA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 0765US2021361649A1Combination therapy with glutaminase inhibitors and immuno-oncology agentsCALITHERA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0864US2010035920A1SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USEAVIGEN INC·Filed 2009·Application pending·0 cites
- 0964US2009318437A1SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USEGAETA FEDERICO C A·Filed 2009·Application pending·0 cites
- 1063US10940148B2Combination therapy with glutaminase inhibitors and immuno-oncology agentsCALITHERA BIOSCIENCES INC·Filed 2019·Granted Mar 9, 2021·0 cites·17 claims
- 1155US2009221629A1Method for antagonizing MIF activityAVIGEN INC·Filed 2009·Application pending·0 cites
- 1254US7622256B2Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1AVIGEN INC·Filed 2007·Granted Nov 24, 2009·0 cites·1 claims
- 1344US11291674B2Arginase inhibitor combination therapiesCALITHERA BIOSCIENCES INC·Filed 2017·Granted Apr 5, 2022·0 cites·35 claims
- 1444US10195197B2Combination therapy with glutaminase inhibitorsCALITHERA BIOSCIENCES INC·Filed 2017·Granted Feb 5, 2019·0 cites·17 claims
- 1543US2020038398A1Combination therapy with glutaminase inhibitorsCALITHERA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1643US2015004134A1Treatment of cancer with heterocyclic inhibitors of glutaminaseCALITHERA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 1742US8119657B2Enantiomeric compositions of 2-amino-1-(2-isopropylpyrazolo[1,5-α]pyridin-3-yl)propan-1-one and related methodsJOHNSON KIRK W·Filed 2010·Granted Feb 21, 2012·0 cites·9 claims
- 1837US2016287564A1Methods of administering glutaminase inhibitorsCALITHERA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 1929US2011039873A1SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITYGAETA FEDERICO C A·Filed 2010·Application pending·0 cites
- 2026US2015258082A1Combination therapy with glutaminase inhibitorsPARLATI FRANCESCO·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →